Evidence map›Paper›PMID 30782845›Full record

ArticleThe Journal of biological chemistry2019

The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.

Peiying Song, Songpeng Yang, Hui Hua, Hongying Zhang, Qingbin Kong, Jiao Wang, Ting Luo, Yangfu Jiang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Targeting mTOR for cancer therapy.Journal of hematology & oncology · 2019
    Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Peiying SongFrom the State Key Laboratory of Biotherapy, Section of Oncogene, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041.
Songpeng YangFrom the State Key Laboratory of Biotherapy, Section of Oncogene, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041.
Hui Huathe Laboratory of Stem Cell Biology, West China Hospital, Chengdu 610041.
Hongying ZhangFrom the State Key Laboratory of Biotherapy, Section of Oncogene, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041.
Qingbin KongFrom the State Key Laboratory of Biotherapy, Section of Oncogene, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041.
Jiao Wangthe School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610075.
Ting Luothe Cancer Center, West China Hospital, Chengdu 610041, China.
Yangfu JiangFrom the State Key Laboratory of Biotherapy, Section of Oncogene, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041. Electronic address: jyangfu@scu.edu.cn.
Sichuan University · CNChengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GADD34 (growth arrest and DNA damage-inducible gene 34) plays a critical role in responses to DNA damage and endoplasmic reticulum stress. GADD34 has opposing effects on different stimuli-induced cell apoptosis events, but the reason for this is unclear. Here, using immunoblotting analyses and various molecular genetic approaches in HepG2 and SMMC-7721 cells, we demonstrate that GADD34 protects hepatocellular carcinoma (HCC) cells from tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by stabilizing a BCL-2 family member, myeloid cell leukemia 1 (MCL-1). We found that GADD34 knockdown decreased MCL-1 levels and that GADD34 overexpression up-regulated MCL-1 expression in HCC cells. GADD34 did not affect

Indexed as

ApoptosisCarcinoma, HepatocellularExtracellular Signal-Regulated MAP KinasesHep G2 CellsHumansIntracellular Signaling Peptides and ProteinsLiver NeoplasmsMyeloid Cell Leukemia Sequence 1 ProteinNeoplasm ProteinsProtein Phosphatase 1Protein StabilityTNF Receptor-Associated Factor 6TNF-Related Apoptosis-Inducing LigandExtracellular Signal-Regulated MAP KinasesIntracellular Signaling Peptides and ProteinsMCL1 protein, humanMyeloid Cell Leukemia Sequence 1 ProteinNeoplasm ProteinsPPP1R15A protein, humanProtein Phosphatase 1Tifab protein, humanTNF Receptor-Associated Factor 6TNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanapoptosiscancerdrug resistanceGADD34MCL-1oncogeneTRAFTrail

Identifiers

PMID30782845
PMCPMC6463698
OpenAlexW2915813276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.